← Browse by Condition
Medical Condition
congenital adrenal hyperplasia
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1, Phase 2
NCT07187375 Phase 2
Recruiting
Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old
Enrollment
6 pts
Location
Germany
Sponsor
Neurocrine Biosciences
NCT04463316
Recruiting
GROWing Up With Rare GENEtic Syndromes
Enrollment
600 pts
Location
Netherlands
Sponsor
dr. Laura C. G. de Graaff-Herd...
NCT05669950 Phase 1, Phase 2
Recruiting
A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
Enrollment
42 pts
Location
United States, Denma...
Sponsor
H. Lundbeck A/S